Seek Returns logo

AZN vs. GH: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at AZN and GH, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.

Company Overview

AZN dominates in value with a market cap of 432.07 billion USD, eclipsing GH’s 4.60 billion USD by roughly 94.03×.

GH carries a higher beta at 1.49, indicating it’s more sensitive to market moves, while AZN remains steadier at 0.18.

AZN trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while GH remains a standard domestic listing.

SymbolAZNGH
Company NameAstraZeneca PLCGuardant Health, Inc.
CountryGBUS
SectorHealthcareHealthcare
IndustryDrug Manufacturers - GeneralMedical - Diagnostics & Research
CEOMr. Pascal Claude Roland Soriot D.V.M., M.B.A.Dr. Helmy Eltoukhy Ph.D.
Price69.68 USD37.09 USD
Market Cap432.07 billion USD4.60 billion USD
Beta0.181.49
ExchangeNASDAQNASDAQ
IPO DateMay 12, 1993October 4, 2018
ADRYesNo

Performance Comparison

This chart compares the performance of AZN and GH over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Hover over the lines to see the investment’s value and total return (%) at specific dates.

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

The section examines key financial ratios to assess the valuation of AZN and GH based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.

  • GH shows a negative P/E of -11.03, highlighting a year of losses, whereas AZN at 27.80 trades on solid profitability.
  • GH carries a sub-zero price-to-book ratio of -18.32, indicating negative equity. In contrast, AZN (P/B 5.26) has positive book value.
  • GH reports a negative Price-to-Free Cash Flow ratio of -15.07, showing a cash flow shortfall that could threaten its operational sustainability, while AZN at 22.33 maintains positive cash flow.
SymbolAZNGH
Price-to-Earnings Ratio (P/E, TTM)27.80-11.03
Forward PEG Ratio (TTM)2.500.46
Price-to-Sales Ratio (P/S, TTM)3.935.94
Price-to-Book Ratio (P/B, TTM)5.26-18.32
Price-to-Free Cash Flow Ratio (P/FCF, TTM)22.33-15.07
EV-to-EBITDA (TTM)13.68-13.08
EV-to-Sales (TTM)4.416.72
EV-to-Free Cash Flow (TTM)25.07-17.07

Dividend Comparison

AZN delivers a 1.39% dividend yield, blending income with growth, whereas GH appears to retain its profits, possibly to fund operations, R&D, or other growth initiatives.

SymbolAZNGH
Dividend Yield (TTM)1.39%0.00%

Financial Strength Metrics Comparison

This section dives into the financial resilience of AZN and GH, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.

  • AZN’s current ratio of 0.90 signals a possible liquidity squeeze, while GH at 4.11 comfortably covers its short-term obligations.
  • AZN’s quick ratio of 0.70 suggests it may struggle to cover immediate liabilities without selling inventory or raising cash, whereas GH at 3.76 maintains a comfortable buffer of liquid assets.
  • GH has negative equity (debt-to-equity ratio -5.21), suggesting asset shortfalls, whereas AZN at 0.77 preserves healthier equity coverage.
  • GH carries a debt-to-assets ratio of 0.97, suggesting substantial asset funding via debt, while AZN at 0.30 opts for a more conservative financing structure.
  • AZN meets its interest obligations (ratio 7.95). In stark contrast, GH’s negative ratio (-166.83) means its operating earnings (EBIT) don't cover basic operations, let alone interest, signaling serious financial trouble.
SymbolAZNGH
Current Ratio (TTM)0.904.11
Quick Ratio (TTM)0.703.76
Debt-to-Equity Ratio (TTM)0.77-5.21
Debt-to-Assets Ratio (TTM)0.300.97
Interest Coverage Ratio (TTM)7.95-166.83